1. Home
  2. BTBD vs ENSC Comparison

BTBD vs ENSC Comparison

Compare BTBD & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BT Brands Inc.

BTBD

BT Brands Inc.

N/A

Current Price

$1.52

Market Cap

10.1M

ML Signal

N/A

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.41

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTBD
ENSC
Founded
1987
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.2M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
BTBD
ENSC
Price
$1.52
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $4.08
AVG Volume (30 Days)
9.8K
★ 278.3K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.24
EPS
★ N/A
N/A
Revenue
★ $14,823,472.00
$5,066,650.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.03
$0.23
52 Week High
$2.48
$2.16

Technical Indicators

Market Signals
Indicator
BTBD
ENSC
Relative Strength Index (RSI) 41.84 49.44
Support Level $1.10 $0.39
Resistance Level $1.92 $0.44
Average True Range (ATR) 0.14 0.04
MACD -0.03 -0.00
Stochastic Oscillator 39.66 66.38

Price Performance

Historical Comparison
BTBD
ENSC

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: